Expert Health Economics, Payer Strategy & Market Access Consulting
MedNavigate by the Numbers
Years of Experience
Formulary Approvals
MedNavigate Launch Year
Our Mission
At MedNavigate LLC our mission is to empower emerging and mid-size life sciences companies to achieve commercial success by transforming scientific insights into actionable strategies. We specialize in identifying and quantifying unmet patient needs and developing data-driven strategies, tools, and narratives that articulate the true value of new therapies. Our reimbursement consulting services support medical device, biotech and pharmaceutical companies. By working side by side with our clients, we provide scientifically grounded, hands-on support that ensures every step of the journey is guided by evidence, collaboration, and a shared commitment to improving patient outcomes.
Our Vision
At MedNavigate, we envision a world where every patient has timely access to innovative therapies and technologies that meet their unique needs. Our commitment to excellence drives us to continuously refine our methodologies and expand our expertise, ensuring that we remain at the forefront of the life sciences industry.
Our Approach
We believe in a collaborative approach that fosters open communication and trust with our clients. By leveraging our deep expertise in health economics, evidence strategy and payer engagement, we help our partners navigate the complexities of the healthcare landscape. Our tailored solutions are designed to empower our clients to make informed decisions that enhance patient care and drive business growth.
Education:
PhD – Public Health Sciences, Health Policy Tract, University of Illinois, Chicago.
MBA – Western Michigan Univerisity.
BS Pharmacy – Ferris State University
About Nancy Hedlund
As an advisor, Nancy Hedlund, PhD, MBA, RPh, brings a unique combination of analytical expertise, industry knowledge, and strategic insight. With advanced training in health economics and outcomes research, she excels at synthesizing complex data and translating it into compelling value stories that resonate with stakeholders across the healthcare landscape. She partners this with 15 years of clinical health system experience to devise strategies that are both on target and practical.
Health Economics, Payer Strategy and Market Access Leader
Dr. Hedlund has partnered with organizations of all sizes, ranging from early-stage startups to top-50 global life sciences companies. Her team has guided clients through critical projects by providing both strategic insights and tactical hands-on support to enable market access.
Her professional portfolio includes leadership roles with:
- Astellas
- Baxter Healthcare Corporation
- Hospira (a Pfizer Company)
- AmerisourceBergen
She also has nearly 15 years of clinical experience as a clinical and operations pharmacist. Nancy has built and led cross-functional teams, collaborating with medical and marketing leaders to develop operational and evidence-based strategies that improve patient care and enable product adoption.
Biotechnology Commercialization and Life Sciences Instructor
A recognized thought leader, Dr. Hedlund serves as adjunct faculty within the McCormick College of Engineering at Northwestern University in Evanston, Illinois. She has developed curriculum and currently teaches a Fundamentals of Biotech Commercialization lecture course and a Biotechnology Commercialization Practicum for first year masters in biotechnology students.Nancy is an active member of several professional organizations, including ISPOR, AMCP, Women in BIO (WIB), HerCSuite, and RxRoundtable. She is also a credentialed consultant with AmplerExAdvisory and A-Connect.
Driving Innovation in Life Sciences and Healthcare Market Access
Nancy’s commitment to fostering innovation extends beyond her advisory roles. She actively engages in research initiatives that aim to bridge the gap between scientific discovery and practical application in healthcare. By collaborating with academic institutions and industry leaders, she seeks to create pathways that enhance the development and accessibility of groundbreaking therapies. Her passion for mentorship also drives her to inspire the next generation of healthcare professionals, ensuring that they are equipped with the knowledge and skills necessary to navigate the evolving landscape of life sciences.
Patient-Centered Care Advocacy in Life Sciences
In addition to her professional endeavors, Nancy is a staunch advocate for patient-centered care. She believes that understanding the patient journey is crucial for developing effective healthcare solutions. Through her work, she emphasizes the importance of incorporating patient perspectives into research and policy-making, ultimately striving to improve health outcomes and quality of life for individuals across diverse populations.
Check Out Some of Our Work
Selected Publications
The Patient Perspective of Living with Recurrent Respiratory Papillomatosis. Pai SI, Ochieng W, Hedlund N, et al. The Laryngoscope. 2026. doi:10.1002/lary.70412
Real-World Use of FLT3-TKIs in R/R FLT3-Mutated AML in the United States. Grinblatt DL, Pandya B, Han W, Sullivan L, Feng Q, Hedlund N. Blood. 2020, vol 136. American Society of Hematology conference abstract (Nov. 5, 2020).
Real-world analysis of prostate-specific antigen (PSA) outcomes among patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide (ENZA). Stephen J. Freedland, Neil M. Schultz, Anna D. Coutinho, Rupali Fuldeore, Nancy Hedlund, Qi Feng, Krishnan Ramaswamy, and Agnes Hong. Journal of Clinical Oncology. 2020; 38:6 suppl, 33-33.
Drug shortage impacts patient receipt of induction treatment. NG Hedlund, Z Isgor, J Zwanziger, D Rondelli, SY Crawford, DM Hynes, LM Powell. Health services research. 2018; 53 (6), 5078-5105. https://doi.org/10.1111/1475-6773.1302.
Systematic evidence review of rates and burden of harm of intravenous admixture drug preparation errors in healthcare settings. N Hedlund, I Beer, T Hoppe-Tichy, P Trbovich. BMJ open. 2017; 7 (12), e015912.
Primary intravenous set consumption across 3 branded infusion pumps.N Hedlund, S Sarangpur, S Kayler, K O’Brien, I Beer. Journal of Infusion Nursing. 2017; 40 (4), 206.
Hedlund, NG. (2017) Impact of drug shortages on patient treatment and survival: The case of cytarabine and AML leukemia. [Doctoral dissertation, University of Illinois at Chicago, Chicago, IL]. ProQuest Dissertations Publishing.
A systematic review of trends, rates and burden of harm associated with intravenous drug preparation errors in healthcare settings (PS-058). N Hedlund. European Journal of Hospital Pharmacy. 2015; 22 (Suppl 1), A159-A159.
Dissemination of patient navigation programs across the United States.N Hedlund, BC Risendal, H Pauls, PA Valverde, E Whitley, A Esparza, E Calhoun. Journal of Public Health Management and Practice. 2014; 20 (4), E15-E24.
Evaluating the cost-effectiveness of using boceprevir and telaprevir in the treatment of newly diagnosed Hepatitis C genotype 1 patients: A payer’s perspective. YJ Jalundhwala, P Patel, N Hedlund, W Cheng, B Manzoor, H Patel, D Touchette. Pharmacotherapy. 2012; 32 (10), E300-E301.
The importance of staff diversity to address disparity. Nancy Hedlund, Angelina Esparza, Jerome Yates. Physician executive. 2012; 38 (5), 6
Proceedings of a summit on preventing patient harm and death from iv medication errors Bona Benjamin, Hedlund N, et. al. American Journal of Health-system Pharmacy. 2011; 65 (24), 2367-2379.
Patents
Systems and methods for a graphical interface including a graphical representation of medical data. JA Hume, R Mayer, DA Lee, G Christensen, C Arvelo, TL Ruchti, TBan, MM Khair, NG Hedlund. US Patent 10,430,761 [2019].
System and method for comparing and utilizing activity information and configuration information from multiple medical device management systems. SI Butler, TM Dunsirn, DE Frede, NG Hedlund, TF Polonus, SJ Pregulman, TJ Ramaker, JE Tillery, MK Van Huis. US Patent 10,242,060 [2019].